
    
      Participants were randomized to 4 different groups to receive either CYD dengue vaccine
      and/or YF vaccine. Participants who already received YF vaccine prior to enrolment were
      randomized to one of the 2 groups receiving CYD dengue vaccine alone. Participants were
      evaluated for immunogenicity, antibody persistence, reactogenicity and safety.
    
  